- Home
- GBTG vs CNTA Comparison
GBTG vs CNTA Comparison
Compare GBTG & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GBTG | CNTA |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | United Kingdom | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.5B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GBTG | CNTA |
|---|---|---|
| Price | $5.56 | $39.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $9.40 | ★ $42.14 |
| AVG Volume (30 Days) | 1.5M | ★ 3.7M |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 173.33 | 29.13 |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $2,718,000,000.00 | $15,000,000.00 |
| Revenue This Year | $22.44 | N/A |
| Revenue Next Year | $4.36 | N/A |
| P/E Ratio | $25.36 | ★ N/A |
| Revenue Growth | ★ 12.17 | N/A |
| 52 Week Low | $4.96 | $9.60 |
| 52 Week High | $8.64 | $40.26 |
Technical Indicators
Market Signals| Indicator | GBTG | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | 77.51 |
| Support Level | $5.29 | $22.49 |
| Resistance Level | $5.86 | N/A |
| Average True Range (ATR) | 0.19 | 1.56 |
| MACD | 0.04 | 1.30 |
| Stochastic Oscillator | 59.20 | 96.36 |
Price Performance
Historical ComparisonAbout GBTG Global Business Travel Group Inc.
Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.